Showing results (121-130 of 145) with videos related to

Sort By:
Pageof 15
The New England Journal of Medicine|March 18, 1993
A comparison of management patterns after acute myocardial infarction in Canada and the United States. The SAVE investigatorsJ L Rouleau, L A Moyé, M A Pfeffer, et al.
European Heart Journal|May 1, 1994
Uniformity of captopril benefit in the SAVE Study: subgroup analysis. Survival and Ventricular Enlargement StudyL A Moyé, M A Pfeffer, C C Wun, et al.
Circulation|January 1, 1994
Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captoprilM St John Sutton, M A Pfeffer, T Plappert, et al.
The New England Journal of Medicine|September 13, 1992
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE InvestigatorsM A Pfeffer, E Braunwald, L A Moyé, et al.
JAMA|July 24, 1991
Selection bias in the use of thrombolytic therapy in acute myocardial infarction. The SAVE InvestigatorsM A Pfeffer, L A Moyé, E Braunwald, et al.
Circulation|September 1, 1995
Effect of infarct artery patency on prognosis after acute myocardial infarction. The Survival and Ventricular Enlargement InvestigatorsG A Lamas, G C Flaker, G Mitchell, et al.
Circulation|October 1, 1986
Left ventricular remodeling after myocardial infarction: a corollary to infarct expansionR G McKay, M A Pfeffer, R C Pasternak, et al.
Circulation|December 13, 1997
Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trialM St John Sutton, M A Pfeffer, L Moye, et al.
Circulation|October 1, 1994
Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE InvestigatorsJ D Rutherford, M A Pfeffer, L A Moyé, et al.
Circulation|December 8, 1998
Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care InvestigatorsR B Goldberg, M J Mellies, F M Sacks, et al.
Pageof 15